Loading clinical trials...
Loading clinical trials...
Impact of CardiolRx on Myocardial Recovery in Acute Myocarditis. A Double-blind, Placebo-controlled Trial
Conditions
Interventions
CardiolRx
Locations
37
United States
MedStar Heart and Vascular Institute
Washington D.C., District of Columbia, United States
Massachusetts General Hospital site
Boston, Massachusetts, United States
Minneapolis Heart Institute Foundation
Minneapolis, Minnesota, United States
Cleveland Clinic
Cleveland, Ohio, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Virginia Commonwealth University
Richmond, Virginia, United States
Start Date
June 22, 2022
Primary Completion Date
January 31, 2025
Completion Date
February 4, 2025
Last Updated
March 12, 2025
NCT07371689
NCT06478667
NCT03018834
NCT02905721
Lead Sponsor
Cardiol Therapeutics Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions